Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with mild-moderate fibrosis, with or without glucose abnormalities: interim results of the EGG18 study. (February 2020) - Calvaruso, V.; Petta, S.; Ferraro, D.; La Mantia, C.; Reina, G.; Zarcone, A.; Assanto, E.; Di Marco, V.; Craxì, A.